CrowdStrike is likely to see its shares rise as Mythos’ limited roll out acts as a catalyst for cybersecurity spending, according to Key Banc.
Source: US Top News and Analysis
News Aggregation on Steroids
CrowdStrike is likely to see its shares rise as Mythos’ limited roll out acts as a catalyst for cybersecurity spending, according to Key Banc.
Source: US Top News and Analysis